0 Items
Toll Free (US) - +1-866-598-1553
sales@precisionbusinessinsights.com
Cell Therapy Market: Global Market Estimation, Dynamics, Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

Cell Therapy Market: Global Market Estimation, Dynamics, Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00 – $ 8,900.00

Cell Therapy Market: By Cell Type (Stem Cell Therapy (Bone Marrow, Blood, Umbilical Cord-Derived, Adipose-Derived Stem Cell, Others), Non-Stem Cell Therapy), By Therapy Type (Allogeneic and Autologous), By Indication (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, Others) and Geography

 

Request Sample Request Methodology
Request Sample Read More
$ PRICE - $ 3,000.00 – $ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00 – $ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:
Report

Description

Cell Therapy Market size was valued at USD 8.22 billion in 2021, growing at a significant CAGR of 13.3 % from 2022-2028. Rising in the number of medical research facilities and number of clinical trials centers for development of effective and novel medical solutions for patients as early as possible to diagnosis and treatment of chronic disease such as cancer, cardiac abnormalities and others. Furthermore, new innovations, technological advancement in the medical sector, and rising government initiatives for enhancing the better advance medical facilities will propel the market growth. However, high cost of research and low success rate are some of the factors expected to hinder the market growth. Cell therapy is the use of transplanted human cells to replace or treat diseased tissue and/or cells. With the use of cutting-edge technologies, innovative products, and limitless imagination, a variety of distinct cell types may be utilised as part of a therapy or treatment for a range of diseases and disorders. In order to achieve a therapeutic outcome, it is a type of treatment in which a patient receives living cells via injection, grafting, or implant.

Key Developments:

In 2018, Thermo Fisher Scientific launched an advanced laboratory management system for data integrity and complete regulatory compliance.

Cell Therapy Market

MARKET SUMMARY
-
13.3% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 13.3%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Cell Therapy Market

  • The report gives comprehensive outlook on cell therapy across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report gives historical, current, and future market sizes (US$ Mn) on the basis of type, technology, cell source, application, end-user and region.
Key Players
  • ReproCELL
  • Prima BioMed
  • Q Therapeutics
  • Tessa Therapeutics
  • Sangamo BioSciences
  • VistaGen Therapeutics
Cell Therapy Market Dynamics

Changing in the lifestyle and food habits rising in numerous of chronic diseases such as cancer, cardiovascular disease, neurodegenerative disorder and others thus increasing in the demand of huge number of advanced medical facilities which provide highly advanced treatment. Scientists are continuously researching and developing high-performance novel drug solutions thus to provide conventional diagnosis and treatment to the patients. Increasing government emphasis on clinical trials and cell therapy doses to develop the healthcare infrastructure. Moreover, rising disposable income, technological advancement and rising popularity of cell therapy will fuel the market growth during the forecast period.

North-America Got Significant Share

Cell Therapy Market

North America accounted for larger revenue share in global cell therapy market with considerable CAGR. The growth in this region, especially in USA and Canada can be attributed to rising in the medical center and cost effective treatment. For instance, government of Canada has initiated Strategic Innovation Fund Program that invests in research activities carried out for stem cell therapies permitting development in stem cell therapy. European market dominates by advanced healthcare facility systems. European region is expected to dominate the market growth due to economically developed countries such as Germany, UK and France. In Asia Pacific cell therapy market is largely driven by the developing healthcare infrastructure, and skilled professionals, increase in disposable incomes.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast.
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Cell Therapy Market Segmentation

segmentation-block-image

By Cell Type

    • Reagents and Kits
    • Instruments
    • Software
segmentation-block-image

By Therapy Type

    • Allogenic Therapies
    • Autologous Therapies
segmentation-block-image

By Indication

    • Malignancies
    • Musculoskeletal Disorders
    • Autoimmune Disorders
    • Dermatology
    • Others
segmentation-block-image

End User

    • Biopharmaceutical and Biotechnology Industries
    • Hospitals and Clinics
    • Academic and Research Institutes
    • Others
Location

GEOGRAPHY

Frequently Asked Questions

The cell therapy market is projected to expand at a CAGR of 13.3% during the forecast period

 

 

 

 

ReproCELL, Prima BioMed, Q Therapeutics, Tessa Therapeutics, Sangamo BioSciences, VistaGen Therapeutics

North America  is the fastest-growing region for cell therapy market

Report

Table Of Content

1. Executive Summary
2. Global Cell Therapy Market Introduction
2.1. Global Cell Therapy Market – Taxonomy
2.2. Global Cell Therapy Market –Definitions
2.2.1. Cell Type
2.2.2. Therapy Type
2.2.3. Indication
2.2.4. Region
3. Global Cell Therapy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Current Trends
3.5. Global Cell Therapy Market Dynamic Factors – Impact Analysis
3.6. Mergers, Acquisitions, and Collaborations
4. Global Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cell Therapy Market, By Cell Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Stem Cell Therapy
5.1.1. Bone Marrow
5.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Blood
5.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Umbilical Cord-Derived
5.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Adipose-Derived Stem Cell
5.1.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.1.5. Others
5.1.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.5.3. Market Opportunity Analysis
5.2. Non-Stem Cell Therapy
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Cell Therapy Market, By Therapy Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. Allogenic Therapies
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Autologous Therapies
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Cell Therapy Market, By Indication, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. Malignancies
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Musculoskeletal Disorders
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Autoimmune Disorders
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Dermatology
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Cell Therapy Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. MEA
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Cell Therapy Market – Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, and Country, 2022 – 2028
9. North America Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Cell Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Stem Cell Therapy
9.1.1.1. Bone Marrow
9.1.1.2. Blood
9.1.1.3. Umbilical Cord-Derived
9.1.1.4. Adipose-Derived Stem Cell
9.1.1.5. Others
9.1.2. Non-Stem Cell Therapy
9.2. Therapy Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Allogenic Therapies
9.2.2. Autologous Therapies
9.3. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Malignancies
9.3.2. Musculoskeletal Disorders
9.3.3. Autoimmune Disorders
9.3.4. Dermatology
9.3.5. Others
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.4.1. United States
9.4.2. Canada
9.5. North America Cell Therapy Market – Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027
9.6. North America Cell Therapy Market Dynamics – Trends
10. Europe Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Cell Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Stem Cell Therapy
10.1.1.1. Bone Marrow
10.1.1.2. Blood
10.1.1.3. Umbilical Cord-Derived
10.1.1.4. Adipose-Derived Stem Cell
10.1.1.5. Others
10.1.2. Non-Stem Cell Therapy
10.2. Therapy Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Allogenic Therapies
10.2.2. Autologous Therapies
10.3. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Malignancies
10.3.2. Musculoskeletal Disorders
10.3.3. Autoimmune Disorders
10.3.4. Dermatology
10.3.5. Others
10.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. UK
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe Cell Therapy Market – Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027
10.6. Europe Cell Therapy Market Dynamics – Trends
11. Asia Pacific Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Cell Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Stem Cell Therapy
11.1.1.1. Bone Marrow
11.1.1.2. Blood
11.1.1.3. Umbilical Cord-Derived
11.1.1.4. Adipose-Derived Stem Cell
11.1.1.5. Others
11.1.2. Non-Stem Cell Therapy
11.2. Therapy Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Allogenic Therapies
11.2.2. Autologous Therapies
11.3. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Malignancies
11.3.2. Musculoskeletal Disorders
11.3.3. Autoimmune Disorders
11.3.4. Dermatology
11.3.5. Others
11.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. ANZ
11.4.4. Japan
11.4.5. Rest of APAC
11.5. Asia Pacific Cell Therapy Market – Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027
11.6. Asia Pacific Cell Therapy Market Dynamics – Trends
12. MEA Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Cell Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Stem Cell Therapy
12.1.1.1. Bone Marrow
12.1.1.2. Blood
12.1.1.3. Umbilical Cord-Derived
12.1.1.4. Adipose-Derived Stem Cell
12.1.1.5. Others
12.1.2. Non-Stem Cell Therapy
12.2. Therapy Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Allogenic Therapies
12.2.2. Autologous Therapies
12.3. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Malignancies
12.3.2. Musculoskeletal Disorders
12.3.3. Autoimmune Disorders
12.3.4. Dermatology
12.3.5. Others
12.4. Country Level Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of MEA
12.5. MEA Cell Therapy Market – Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027
12.6. MEA Cell Therapy Market Dynamics – Trends
13. Latin America Cell Therapy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Cell Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Stem Cell Therapy
13.1.1.1. Bone Marrow
13.1.1.2. Blood
13.1.1.3. Umbilical Cord-Derived
13.1.1.4. Adipose-Derived Stem Cell
13.1.1.5. Others
13.1.2. Non-Stem Cell Therapy
13.2. Therapy Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Allogenic Therapies
13.2.2. Autologous Therapies
13.3. Indication Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Malignancies
13.3.2. Musculoskeletal Disorders
13.3.3. Autoimmune Disorders
13.3.4. Dermatology
13.3.5. Others
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Argentina
13.4.4. Rest of LA
13.5. Latin America Cell Therapy Market – Opportunity Analysis Index, By Cell Type, Therapy Type, Indication, 2016-2027
13.6. Latin America Cell Therapy Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Anterogen Co., Ltd.
14.2.2. Capricor Therapeutics
14.2.3. Celgene Corporation
14.2.4. PHARMICELL Co., Ltd
14.2.5. JCR Pharmaceuticals Co., Ltd.
14.2.6. NuVasive, Inc.
14.2.7. Kolon TissueGene, Inc.
14.2.8. Osiris Therapeutics, Inc.
14.2.9. Castle Creek Biosciences, Inc.
14.2.10. Vericel Corporation
14.2.11. Prima BioMed
14.2.12. Q Therapeutics
14.2.13. Tessa Therapeutics
14.2.14. Sangamo BioSciences
14.2.15. VistaGen Therapeutics
14.2.16. Shire Regenerative Medicine
14.2.17. Bellicum Pharmaceuticals
14.2.18. Antibe Therapeutics
14.2.19. BrainStorm Cell Therapeutics
14.2.20. Fate Therapeutics
14.2.21. Cytori Therapeutics
14.2.22. Immunocellular Therapeutics
15. Research Methodology
16. Key Assumptions and Acronyms
Report

Company Profile

  • ReproCELL
  • Holostem Terapie Avanzate
  • Immunocellular Therapeutics
  • Anterogen
  • Capricor Therapeutics
  • Celgene Corporation
  • PHARMICEL
  • JCR Pharmaceuticals
  • NuVasive
  • Kolon TissueGene, Inc.
  • Osiris Therapeutics, Inc.
  • Castle Creek Biosciences, Inc.
  • Vericel Corporation
  • Prima BioMed
  • Q Therapeutics
  • Tessa Therapeutics
  • Sangamo BioSciences
  • VistaGen Therapeutics
  • Shire Regenerative Medicine
  • Bellicum Pharmaceuticals
  • Antibe Therapeutics
  • BrainStorm Cell Therapeutics
  • Fate Therapeutics
  • Cytori Therapeutics

Description

Cell Therapy Market size was valued at USD 8.22 billion in 2021, growing at a significant CAGR of 13.3 % from 2022-2028. Rising in the number of medical research facilities and number of clinical trials centers for development of effective and novel medical solutions for patients as early as possible to diagnosis and treatment of chronic disease such as cancer, cardiac abnormalities and others. Furthermore, new innovations, technological advancement in the medical sector, and rising government initiatives for enhancing the better advance medical facilities will propel the market growth. However, high cost of research and low success rate are some of the factors expected to hinder the market growth. Cell therapy is the use of transplanted human cells to replace or treat diseased tissue and/or cells. With the use of cutting-edge technologies, innovative products, and limitless imagination, a variety of distinct cell types may be utilised as part of a therapy or treatment for a range of diseases and disorders. In order to achieve a therapeutic outcome, it is a type of treatment in which a patient receives living cells via injection, grafting, or implant.

Key Developments:

In 2018, Thermo Fisher Scientific launched an advanced laboratory management system for data integrity and complete regulatory compliance.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX

QUICKLINKS
RESEARCH AREAS
PRESS RELEASE
CONTACT US
+1-866-598-1553
EMAIL
sales@precisionbusinessinsights.com
FOLLOW US
QUICK LINKS+
RESEARCH AREAS+
PRESS RELEASE+
CONTACT US+
+1-866-598-1553
sales@precisionbusinessinsights.com
FOLLOW US AT+